{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:32:19Z","timestamp":1792549939183,"version":"4.5.0"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1038\/s41574-024-00970-4","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T10:02:05Z","timestamp":1711015325000},"page":"414-425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Endocrine and cellular physiology and pathology of the insulin-like growth factor acid-labile subunit"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5061-2142","authenticated-orcid":false,"given":"Robert C.","family":"Baxter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"970_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0304-4165(66)90124-3","volume":"121","author":"H B\u00fcrgi","year":"1966","unstructured":"B\u00fcrgi, H., M\u00fcller, W. A., Humbel, R. E., Labhart, A. & Froesch, E. R. Non-suppressible insulin-like activity of human serum. I. Physicochemical properties, extraction and partial purification. Biochim. Biophys. Acta 121, 349\u2013359 (1966).","journal-title":"Biochim. Biophys. Acta"},{"key":"970_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/0003-9861(75)90296-9","volume":"168","author":"J Zapf","year":"1975","unstructured":"Zapf, J., Waldvogel, M. & Froesch, E. R. Binding of nonsuppressible insulin-like activity to human serum. Evidence for a carrier protein. Arch. Biochem. Biophys. 168, 638\u2013645 (1975).","journal-title":"Arch. Biochem. Biophys."},{"key":"970_CR3","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1210\/jcem-45-5-988","volume":"45","author":"RL Hintz","year":"1977","unstructured":"Hintz, R. L. & Liu, F. Demonstration of specific plasma protein binding sites for somatomedin. J. Clin. Endocrinol. Metab. 45, 988\u2013995 (1977).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR4","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1172\/JCI111836","volume":"75","author":"JR Wilkins","year":"1985","unstructured":"Wilkins, J. R. & D\u2019Ercole, A. J. Affinity-labeled plasma somatomedin-C\/insulin-like growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure. J. Clin. Invest. 75, 1350\u20131358 (1985).","journal-title":"J. Clin. Invest."},{"key":"970_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1210\/jcem-51-1-12","volume":"51","author":"RW Furlanetto","year":"1980","unstructured":"Furlanetto, R. W. The somatomedin C binding protein: evidence for a heterologous subunit structure. J. Clin. Endocrinol. Metab. 51, 12\u201319 (1980).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0300-595X(84)80007-9","volume":"13","author":"RL Hintz","year":"1984","unstructured":"Hintz, R. L. Plasma forms of somatomedin and the binding protein phenomenon. Clin. Endocrinol. Metab. 13, 31\u201342 (1984).","journal-title":"Clin. Endocrinol. Metab."},{"key":"970_CR7","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1016\/S0021-9258(19)84446-0","volume":"261","author":"JL Martin","year":"1986","unstructured":"Martin, J. L. & Baxter, R. C. Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J. Biol. Chem. 261, 8754\u20138760 (1986).","journal-title":"J. Biol. Chem."},{"key":"970_CR8","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1210\/mend-2-12-1176","volume":"2","author":"WI Wood","year":"1988","unstructured":"Wood, W. I. et al. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol. Endocrinol. 2, 1176\u20131185 (1988).","journal-title":"Mol. Endocrinol."},{"key":"970_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1210\/jcem-67-2-265","volume":"67","author":"RC Baxter","year":"1988","unstructured":"Baxter, R. C. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J. Clin. Endocrinol. Metab. 67, 265\u2013272 (1988).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR10","doi-asserted-by":"publisher","first-page":"11843","DOI":"10.1016\/S0021-9258(18)80143-0","volume":"264","author":"RC Baxter","year":"1989","unstructured":"Baxter, R. C., Martin, J. L. & Beniac, V. A. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. J. Biol. Chem. 264, 11843\u201311848 (1989).","journal-title":"J. Biol. Chem."},{"key":"970_CR11","first-page":"870","volume":"6","author":"SR Leong","year":"1992","unstructured":"Leong, S. R., Baxter, R. C., Camerato, T., Dai, J. & Wood, W. I. Structure and functional expression of the acid-labile subunit of the insulin-like growth factor-binding protein complex. Mol. Endocrinol. 6, 870\u2013876 (1992).","journal-title":"Mol. Endocrinol."},{"key":"970_CR12","doi-asserted-by":"publisher","first-page":"6898","DOI":"10.1073\/pnas.86.18.6898","volume":"86","author":"RC Baxter","year":"1989","unstructured":"Baxter, R. C. & Martin, J. L. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. Proc. Natl Acad. Sci. USA 86, 6898\u20136902 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"970_CR13","first-page":"243","volume":"83","author":"KL Cohen","year":"1976","unstructured":"Cohen, K. L. & Nissley, S. P. The serum half-life of somatomedin activity: evidence for growth hormone dependence. Acta Endocrinol. 83, 243\u2013258 (1976).","journal-title":"Acta Endocrinol."},{"key":"970_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/jcem-47-1-91","volume":"47","author":"RC Franklin","year":"1978","unstructured":"Franklin, R. C., Rennie, G. C., Burger, H. G. & Cameron, D. P. Changes in NSILA-S in response to somatotropin administration and hypophysectomy. J. Clin. Endocrinol. Metab. 47, 91\u201396 (1978).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR15","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1172\/JCI112742","volume":"78","author":"RC Baxter","year":"1986","unstructured":"Baxter, R. C. & Martin, J. L. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J. Clin. Invest. 78, 1504\u20131512 (1986).","journal-title":"J. Clin. Invest."},{"key":"970_CR16","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1210\/jcem-70-5-1347","volume":"70","author":"RC Baxter","year":"1990","unstructured":"Baxter, R. C. Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. J. Clin. Endocrinol. Metab. 70, 1347\u20131353 (1990).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR17","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00018-008-8019-0","volume":"65","author":"J Bella","year":"2008","unstructured":"Bella, J., Hindle, K. L., McEwan, P. A. & Lovell, S. C. The leucine-rich repeat structure. Cell Mol. Life Sci. 65, 2307\u20132333 (2008).","journal-title":"Cell Mol. Life Sci."},{"key":"970_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2174\/0929866526666181208170027","volume":"26","author":"N Matsushima","year":"2019","unstructured":"Matsushima, N., Takatsuka, S., Miyashita, H. & Kretsinger, R. H. Leucine rich repeat proteins: sequences, mutations, structures and diseases. Protein Pept. Lett. 26, 108\u2013131 (2019).","journal-title":"Protein Pept. Lett."},{"key":"970_CR19","doi-asserted-by":"publisher","first-page":"23328","DOI":"10.1074\/jbc.274.33.23328","volume":"274","author":"JB Janosi","year":"1999","unstructured":"Janosi, J. B. et al. The acid-labile subunit of the serum insulin-like growth factor-binding protein complexes. Structural determination by molecular modeling and electron microscopy. J. Biol. Chem. 274, 23328\u201323332 (1999).","journal-title":"J. Biol. Chem."},{"key":"970_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1530\/JME-12-0086","volume":"49","author":"A David","year":"2012","unstructured":"David, A., Kelley, L. A. & Sternberg, M. J. A new structural model of the acid-labile subunit: pathogenetic mechanisms of short stature-causing mutations. J. Mol. Endocrinol. 49, 213\u2013220 (2012).","journal-title":"J. Mol. Endocrinol."},{"key":"970_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32214-2","volume":"13","author":"H Kim","year":"2022","unstructured":"Kim, H. et al. Structural basis for assembly and disassembly of the IGF\/IGFBP\/ALS ternary complex. Nat. Commun. 13, 4434 (2022).","journal-title":"Nat. Commun."},{"key":"970_CR22","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1534\/genetics.108.099531","volume":"181","author":"LE Swanson","year":"2009","unstructured":"Swanson, L. E. et al. Drosophila convoluted\/dALS is an essential gene required for tracheal tube morphogenesis and apical matrix organization. Genetics 181, 1281\u20131290 (2009).","journal-title":"Genetics"},{"key":"970_CR23","doi-asserted-by":"publisher","first-page":"9252","DOI":"10.1074\/jbc.M117.783639","volume":"292","author":"P Rotwein","year":"2017","unstructured":"Rotwein, P. Large-scale analysis of variation in the insulin-like growth factor family in humans reveals rare disease links and common polymorphisms. J. Biol. Chem. 292, 9252\u20139261 (2017).","journal-title":"J. Biol. Chem."},{"key":"970_CR24","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1074\/jbc.274.9.5292","volume":"274","author":"JB Janosi","year":"1999","unstructured":"Janosi, J. B., Firth, S. M., Bond, J. J., Baxter, R. C. & Delhanty, P. J. N-linked glycosylation and sialylation of the acid-labile subunit. Role in complex formation with insulin-like growth factor (IGF)-binding protein-3 and the IGFs. J. Biol. Chem. 274, 5292\u20135298 (1999).","journal-title":"J. Biol. Chem."},{"key":"970_CR25","first-page":"42","volume":"6","author":"SR Holman","year":"1996","unstructured":"Holman, S. R. & Baxter, R. C. Insulin-like growth factor binding protein-3: factors affecting binary and ternary complex formation. Growth Regul. 6, 42\u201347 (1996).","journal-title":"Growth Regul."},{"key":"970_CR26","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1210\/endo.136.11.7588232","volume":"136","author":"CY Lee","year":"1995","unstructured":"Lee, C. Y. & Rechler, M. M. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs. Endocrinology 136, 4982\u20134989 (1995).","journal-title":"Endocrinology"},{"key":"970_CR27","first-page":"186","volume":"35","author":"KY Choi","year":"2002","unstructured":"Choi, K. Y. & Lee, D. H. Interaction between acid-labile subunit and insulin-like growth factor binding protein 3 expressed in Xenopus oocytes. J. Biochem. Mol. Biol. 35, 186\u2013193 (2002).","journal-title":"J. Biochem. Mol. Biol."},{"key":"970_CR28","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1074\/jbc.273.5.2631","volume":"273","author":"SM Firth","year":"1998","unstructured":"Firth, S. M., Ganeshprasad, U. & Baxter, R. C. Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3. J. Biol. Chem. 273, 2631\u20132638 (1998).","journal-title":"J. Biol. Chem."},{"key":"970_CR29","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1074\/jbc.273.11.6074","volume":"273","author":"SM Twigg","year":"1998","unstructured":"Twigg, S. M. & Baxter, R. C. Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit. J. Biol. Chem. 273, 6074\u20136079 (1998).","journal-title":"J. Biol. Chem."},{"key":"970_CR30","doi-asserted-by":"publisher","first-page":"28791","DOI":"10.1074\/jbc.273.44.28791","volume":"273","author":"SM Twigg","year":"1998","unstructured":"Twigg, S. M., Kiefer, M. C., Zapf, J. & Baxter, R. C. Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain. J. Biol. Chem. 273, 28791\u201328798 (1998).","journal-title":"J. Biol. Chem."},{"key":"970_CR31","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1210\/endo.134.6.7515002","volume":"134","author":"E Chin","year":"1994","unstructured":"Chin, E., Zhou, J., Dai, J., Baxter, R. C. & Bondy, C. A. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology 134, 2498\u20132504 (1994).","journal-title":"Endocrinology"},{"key":"970_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1677\/joe.1.06824","volume":"189","author":"JW Kim","year":"2006","unstructured":"Kim, J. W. et al. Isolation of the cDNA encoding the acid labile subunit (ALS) of the 150\u2009kDa IGF-binding protein complex in cattle and ALS regulation during the transition from pregnancy to lactation. J. Endocrinol. 189, 583\u2013593 (2006).","journal-title":"J. Endocrinol."},{"key":"970_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1677\/jme.0.0260135","volume":"26","author":"CY Lee","year":"2001","unstructured":"Lee, C. Y. et al. Molecular cloning of the porcine acid-labile subunit (ALS) of the insulin-like growth factor-binding protein complex and detection of ALS gene expression in hepatic and non-hepatic tissues. J. Mol. Endocrinol. 26, 135\u2013144 (2001).","journal-title":"J. Mol. Endocrinol."},{"key":"970_CR34","doi-asserted-by":"publisher","first-page":"113591","DOI":"10.1016\/j.ygcen.2020.113591","volume":"299","author":"E Landi","year":"2020","unstructured":"Landi, E. et al. Expression of acid-labile subunit (ALS) in developing and adult zebrafish and its role in dorso-ventral patterning during development. Gen. Comp. Endocrinol. 299, 113591 (2020).","journal-title":"Gen. Comp. Endocrinol."},{"key":"970_CR35","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/hep4.1741","volume":"5","author":"W Chen","year":"2021","unstructured":"Chen, W. et al. The matrisome genes from hepatitis B-related hepatocellular carcinoma unveiled. Hepatol. Commun. 5, 1571\u20131585 (2021).","journal-title":"Hepatol. Commun."},{"key":"970_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.matbio.2015.06.003","volume":"49","author":"A Naba","year":"2016","unstructured":"Naba, A. et al. The extracellular matrix: tools and insights for the \u2018omics\u2019 era. Matrix Biol. 49, 10\u201324 (2016).","journal-title":"Matrix Biol."},{"key":"970_CR37","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.1074\/mcp.RA117.000469","volume":"18","author":"E Ouni","year":"2019","unstructured":"Ouni, E., Vertommen, D., Chiti, M. C., Dolmans, M. M. & Amorim, C. A. A draft map of the human ovarian proteome for tissue engineering and clinical applications. Mol. Cell Proteom. 18, S159\u2013S173 (2019).","journal-title":"Mol. Cell Proteom."},{"key":"970_CR38","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1046\/j.1471-4159.2002.00979.x","volume":"82","author":"N Wilczak","year":"2002","unstructured":"Wilczak, N. et al. Insulin-like growth factor (IGF)-I binding to a cell membrane associated IGF binding protein-3 acid-labile subunit complex in human anterior pituitary gland. J. Neurochem. 82, 430\u2013438 (2002).","journal-title":"J. Neurochem."},{"key":"970_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1677\/joe.0.1590265","volume":"159","author":"MS Lewitt","year":"1998","unstructured":"Lewitt, M. S. et al. Regulation of insulin-like growth factor-binding protein-3 ternary complex formation in pregnancy. J. Endocrinol. 159, 265\u2013274 (1998).","journal-title":"J. Endocrinol."},{"key":"970_CR40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S0899-9007(01)00811-5","volume":"18","author":"HC Lo","year":"2002","unstructured":"Lo, H. C. et al. Relation of cord serum levels of growth hormone, insulin-like growth factors, insulin-like growth factor binding proteins, leptin, and interleukin-6 with birth weight, birth length, and head circumference in term and preterm neonates. Nutrition 18, 604\u2013608 (2002).","journal-title":"Nutrition"},{"key":"970_CR41","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1210\/jcem.83.12.5311","volume":"83","author":"A Juul","year":"1998","unstructured":"Juul, A. et al. The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency. J. Clin. Endocrinol. Metab. 83, 4408\u20134415 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0022-1759(01)00335-0","volume":"252","author":"S Stadler","year":"2001","unstructured":"Stadler, S. et al. Monoclonal anti-acid-labile subunit oligopeptide antibodies and their use in a two-site immunoassay for ALS measurement in humans. J. Immunol. Methods 252, 73\u201382 (2001).","journal-title":"J. Immunol. Methods"},{"key":"970_CR43","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1210\/endo.139.10.6273","volume":"139","author":"J Frystyk","year":"1998","unstructured":"Frystyk, J. et al. Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in rats. Endocrinology 139, 4286\u20134292 (1998).","journal-title":"Endocrinology"},{"key":"970_CR44","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1210\/endo.134.2.7507839","volume":"134","author":"RC Baxter","year":"1994","unstructured":"Baxter, R. C. & Dai, J. Purification and characterization of the acid-labile subunit of rat serum insulin-like growth factor binding protein complex. Endocrinology 134, 848\u2013852 (1994).","journal-title":"Endocrinology"},{"key":"970_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ghir.2007.07.007","volume":"18","author":"DL Hwang","year":"2008","unstructured":"Hwang, D. L., Lee, P. D. & Cohen, P. Quantitative ontogeny of murine insulin-like growth factor (IGF)-I, IGF-binding protein-3 and the IGF-related acid-labile subunit. Growth Horm. IGF Res. 18, 65\u201374 (2008).","journal-title":"Growth Horm. IGF Res."},{"key":"970_CR46","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1210\/endrev\/bnad008","volume":"44","author":"RC Baxter","year":"2023","unstructured":"Baxter, R. C. Signaling pathways of the insulin-like growth factor binding proteins. Endocr. Rev. 44, 753\u2013778 (2023).","journal-title":"Endocr. Rev."},{"key":"970_CR47","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.18632\/aging.102826","volume":"12","author":"A Santos-Lozano","year":"2020","unstructured":"Santos-Lozano, A. et al. Successful aging: insights from proteome analyses of healthy centenarians. Aging 12, 3502\u20133515 (2020).","journal-title":"Aging"},{"key":"970_CR48","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1210\/endo.135.6.7527331","volume":"135","author":"J Dai","year":"1994","unstructured":"Dai, J. & Baxter, R. C. Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex. Endocrinology 135, 2335\u20132341 (1994).","journal-title":"Endocrinology"},{"key":"970_CR49","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-2007-978717","volume":"31","author":"CY Lee","year":"1999","unstructured":"Lee, C. Y., Cohen, F. J., Wu, H. B., Ooi, G. T. & Rechler, M. M. The absence of 150-kDa insulin-like growth factor complexes in fetal rat serum is not due to a lack of functional acid-labile subunit. Horm. Metab. Res. 31, 182\u2013185 (1999).","journal-title":"Horm. Metab. Res."},{"key":"970_CR50","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.3390\/pharmaceutics13122009","volume":"13","author":"T Schreiter","year":"2021","unstructured":"Schreiter, T. et al. Transcriptome-wide analysis of human liver reveals age-related differences in the expression of select functional gene clusters and evidence for a PPP1R10-governed \u2018aging cascade\u2019. Pharmaceutics 13, 2009 (2021).","journal-title":"Pharmaceutics"},{"key":"970_CR51","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/BF02801330","volume":"7","author":"SH Mandel","year":"1997","unstructured":"Mandel, S. H., Moreland, E., Rosenfeld, R. G. & Gargosky, S. E. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children. Endocrine 7, 351\u2013360 (1997).","journal-title":"Endocrine"},{"key":"970_CR52","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1210\/endo.134.5.7512499","volume":"134","author":"SE Gargosky","year":"1994","unstructured":"Gargosky, S. E., Tapanainen, P. & Rosenfeld, R. G. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats. Endocrinology 134, 2267\u20132276 (1994).","journal-title":"Endocrinology"},{"key":"970_CR53","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/hep.510230424","volume":"23","author":"J Scharf","year":"1996","unstructured":"Scharf, J., Ramadori, G., Braulke, T. & Hartmann, H. Synthesis of insulin-like growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: regulation by insulin, insulinlike growth factor, and growth hormone. Hepatology 23, 818\u2013827 (1996).","journal-title":"Hepatology"},{"key":"970_CR54","first-page":"553","volume":"84","author":"H Olivecrona","year":"1999","unstructured":"Olivecrona, H. et al. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans. J. Clin. Endocrinol. Metab. 84, 553\u2013560 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR55","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1210\/endo.135.3.8070348","volume":"135","author":"J Dai","year":"1994","unstructured":"Dai, J., Scott, C. D. & Baxter, R. C. Regulation of the acid-labile subunit of the insulin-like growth factor complex in cultured rat hepatocytes. Endocrinology 135, 1066\u20131072 (1994).","journal-title":"Endocrinology"},{"key":"970_CR56","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1210\/mend.11.7.9942","volume":"11","author":"GT Ooi","year":"1997","unstructured":"Ooi, G. T., Cohen, F. J., Tseng, L. Y., Rechler, M. M. & Boisclair, Y. R. Growth hormone stimulates transcription of the gene encoding the acid-labile subunit (ALS) of the circulating insulin-like growth factor-binding protein complex and ALS promoter activity in rat liver. Mol. Endocrinol. 11, 997\u20131007 (1997).","journal-title":"Mol. Endocrinol."},{"key":"970_CR57","first-page":"675","volume":"12","author":"GT Ooi","year":"1998","unstructured":"Ooi, G. T., Hurst, K. R., Poy, M. N., Rechler, M. M. & Boisclair, Y. R. Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells. Mol. Endocrinol. 12, 675\u2013687 (1998).","journal-title":"Mol. Endocrinol."},{"key":"970_CR58","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1172\/JCI42894","volume":"121","author":"BC Sos","year":"2011","unstructured":"Sos, B. C. et al. Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2. J. Clin. Invest. 121, 1412\u20131423 (2011).","journal-title":"J. Clin. Invest."},{"key":"970_CR59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0955-2235(95)00006-2","volume":"6","author":"A Barreca","year":"1995","unstructured":"Barreca, A. et al. Functions and regulation of the acid-labile subunit of the 150\u2009K complex. Prog. Growth Factor. Res. 6, 231\u2013239 (1995).","journal-title":"Prog. Growth Factor. Res."},{"key":"970_CR60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/1097-4652(2000)9999:999<000::AID-JCP1036>3.0.CO;2-Y","volume":"186","author":"JG Scharf","year":"2001","unstructured":"Scharf, J. G., Braulke, T., Hartmann, H. & Ramadori, G. Regulation of the components of the 150 kDa IGF binding protein complex in cocultures of rat hepatocytes and Kupffer cells by 3\u2032,5\u2032-cyclic adenosine monophosphate. J. Cell Physiol. 186, 425\u2013436 (2001).","journal-title":"J. Cell Physiol."},{"key":"970_CR61","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1210\/endo.139.1.5671","volume":"139","author":"PJ Delhanty","year":"1998","unstructured":"Delhanty, P. J. & Baxter, R. C. The regulation of acid-labile subunit gene expression and secretion by cyclic adenosine 3\u2032,5\u2032-monophosphate. Endocrinology 139, 260\u2013265 (1998).","journal-title":"Endocrinology"},{"key":"970_CR62","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1006\/bbrc.1998.8089","volume":"243","author":"PJ Delhanty","year":"1998","unstructured":"Delhanty, P. J. Interleukin-1 beta suppresses growth hormone-induced acid-labile subunit mRNA levels and secretion in primary hepatocytes. Biochem. Biophys. Res. Commun. 243, 269\u2013272 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"970_CR63","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1096-6374(98)80114-7","volume":"8","author":"A Barreca","year":"1998","unstructured":"Barreca, A., Ketelslegers, J. M., Arvigo, M., Minuto, F. & Thissen, J. P. Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1beta in vitro. Growth Horm. IGF Res. 8, 217\u2013223 (1998).","journal-title":"Growth Horm. IGF Res."},{"key":"970_CR64","doi-asserted-by":"publisher","first-page":"a004903","DOI":"10.1101\/cshperspect.a004903","volume":"4","author":"RO Hynes","year":"2012","unstructured":"Hynes, R. O. & Naba, A. Overview of the matrisome \u2014 an inventory of extracellular matrix constituents and functions. Cold Spring Harb. Perspect. Biol. 4, a004903 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"970_CR65","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1046\/j.1365-2265.1999.00775.x","volume":"51","author":"E Fernqvist-Forbes","year":"1999","unstructured":"Fernqvist-Forbes, E., Ekberg, K., Lindgren, B. F. & Brismar, K. Splanchnic exchange of insulin-like growth factor binding protein-1 (IGFBP-1), IGF-I and acid-labile subunit (ALS) during normo- and hyper-insulinaemia in healthy subjects. Clin. Endocrinol. 51, 327\u2013332 (1999).","journal-title":"Clin. Endocrinol."},{"key":"970_CR66","first-page":"2534","volume":"80","author":"A Juul","year":"1995","unstructured":"Juul, A. et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J. Clin. Endocrinol. Metab. 80, 2534\u20132542 (1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR67","first-page":"1311","volume":"84","author":"G Van den Berghe","year":"1999","unstructured":"Van den Berghe, G. et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J. Clin. Endocrinol. Metab. 84, 1311\u20131323 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR68","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1210\/endo.134.6.7514998","volume":"134","author":"MS Lewitt","year":"1994","unstructured":"Lewitt, M. S., Saunders, H., Phuyal, J. L. & Baxter, R. C. Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats. Endocrinology 134, 2404\u20132409 (1994).","journal-title":"Endocrinology"},{"key":"970_CR69","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1210\/endo.133.4.7691582","volume":"133","author":"MS Lewitt","year":"1993","unstructured":"Lewitt, M. S., Saunders, H. & Baxter, R. C. Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3. Endocrinology 133, 1797\u20131802 (1993).","journal-title":"Endocrinology"},{"key":"970_CR70","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1172\/JCI112500","volume":"77","author":"J Zapf","year":"1986","unstructured":"Zapf, J., Hauri, C., Waldvogel, M. & Froesch, E. R. Acute metabolic effects and half-lives of intravenously administered insulin-like growth factors I and II in normal and hypophysectomized rats. J. Clin. Invest. 77, 1768\u20131775 (1986).","journal-title":"J. Clin. Invest."},{"key":"970_CR71","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1210\/endo.143.5.8764","volume":"143","author":"SM Firth","year":"2002","unstructured":"Firth, S. M., McDougall, F., McLachlan, A. J. & Baxter, R. C. Impaired blockade of insulin-like growth factor I (IGF-I)-induced hypoglycemia by IGF binding protein-3 analog with reduced ternary complex-forming ability. Endocrinology 143, 1669\u20131676 (2002).","journal-title":"Endocrinology"},{"key":"970_CR72","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1210\/jc.2003-031880","volume":"89","author":"LD Payet","year":"2004","unstructured":"Payet, L. D., Firth, S. M. & Baxter, R. C. The role of the acid-labile subunit in regulating insulin-like growth factor transport across human umbilical vein endothelial cell monolayers. J. Clin. Endocrinol. Metab. 89, 2382\u20132389 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR73","first-page":"2940","volume":"80","author":"S Xu","year":"1995","unstructured":"Xu, S. et al. Insulin-like growth factors (IGFs) and IGF-binding proteins in human skin interstitial fluid. J. Clin. Endocrinol. Metab. 80, 2940\u20132945 (1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR74","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1677\/joe.0.155r001","volume":"155","author":"SC Hughes","year":"1997","unstructured":"Hughes, S. C., Mason, H. D., Franks, S. & Holly, J. M. The insulin-like growth factors (IGFs) in follicular fluid are predominantly bound in the ternary complex. J. Endocrinol. 155, R1\u2013R4 (1997).","journal-title":"J. Endocrinol."},{"key":"970_CR75","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1210\/jcem.82.12.4415","volume":"82","author":"MJ Khosravi","year":"1997","unstructured":"Khosravi, M. J., Diamandi, A., Mistry, J., Krishna, R. G. & Khare, A. Acid-labile subunit of human insulin-like growth factor-binding protein complex: measurement, molecular, and clinical evaluation. J. Clin. Endocrinol. Metab. 82, 3944\u20133951 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR76","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1046\/j.1365-2265.1997.2581078.x","volume":"47","author":"JI Labarta","year":"1997","unstructured":"Labarta, J. I. et al. Immunoblot studies of the acid-labile subunit (ALS) in biological fluids, normal human serum and in children with GH deficiency and GH receptor deficiency before and after long-term therapy with GH or IGF-I respectively. Clin. Endocrinol. 47, 657\u2013666 (1997).","journal-title":"Clin. Endocrinol."},{"key":"970_CR77","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1210\/endo.141.7.7563","volume":"141","author":"SA Wandji","year":"2000","unstructured":"Wandji, S. A., Gadsby, J. E., Simmen, F. A., Barber, J. A. & Hammond, J. M. Porcine ovarian cells express messenger ribonucleic acids for the acid-labile subunit and insulin-like growth factor binding protein-3 during follicular and luteal phases of the estrous cycle. Endocrinology 141, 2638\u20132647 (2000).","journal-title":"Endocrinology"},{"key":"970_CR78","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s11033-018-4559-z","volume":"46","author":"JS Moon","year":"2019","unstructured":"Moon, J. S. & Choi, Y. H. Multiplex PCR for the rapid detection of insulin-like growth factor in the Pacific oyster, Crassostrea gigas: a useful indicator for growth assessment. Mol. Biol. Rep. 46, 1023\u20131031 (2019).","journal-title":"Mol. Biol. Rep."},{"key":"970_CR79","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.mce.2015.04.009","volume":"411","author":"JA Hetz","year":"2015","unstructured":"Hetz, J. A. et al. Growth axis maturation is linked to nutrition, growth and developmental rate. Mol. Cell Endocrinol. 411, 38\u201348 (2015).","journal-title":"Mol. Cell Endocrinol."},{"key":"970_CR80","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cmet.2008.02.003","volume":"7","author":"N Arquier","year":"2008","unstructured":"Arquier, N. et al. Drosophila ALS regulates growth and metabolism through functional interaction with insulin-like peptides. Cell Metab. 7, 333\u2013338 (2008).","journal-title":"Cell Metab."},{"key":"970_CR81","doi-asserted-by":"publisher","first-page":"6868","DOI":"10.1073\/pnas.120172697","volume":"97","author":"I Ueki","year":"2000","unstructured":"Ueki, I. et al. Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proc. Natl Acad. Sci. USA 97, 6868\u20136873 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"970_CR82","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1172\/JCI0215463","volume":"110","author":"S Yakar","year":"2002","unstructured":"Yakar, S. et al. Circulating levels of IGF-1 directly regulate bone growth and density. J. Clin. Invest. 110, 771\u2013781 (2002).","journal-title":"J. Clin. Invest."},{"key":"970_CR83","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1677\/joe.1.06657","volume":"189","author":"S Yakar","year":"2006","unstructured":"Yakar, S. et al. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. J. Endocrinol. 189, 289\u2013299 (2006).","journal-title":"J. Endocrinol."},{"key":"970_CR84","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1074\/jbc.M109.041913","volume":"285","author":"JC Fritton","year":"2010","unstructured":"Fritton, J. C. et al. The insulin-like growth factor-1 binding protein acid-labile subunit alters mesenchymal stromal cell fate. J. Biol. Chem. 285, 4709\u20134714 (2010).","journal-title":"J. Biol. Chem."},{"key":"970_CR85","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s11357-012-9469-8","volume":"35","author":"HW Courtland","year":"2013","unstructured":"Courtland, H. W. et al. Low levels of plasma IGF-1 inhibit intracortical bone remodeling during aging. Age 35, 1691\u20131703 (2013).","journal-title":"Age"},{"key":"970_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-8-353","volume":"8","author":"WR Swindell","year":"2007","unstructured":"Swindell, W. R. Gene expression profiling of long-lived dwarf mice: longevity-associated genes and relationships with diet, gender and aging. BMC Genomics 8, 353 (2007).","journal-title":"BMC Genomics"},{"key":"970_CR87","doi-asserted-by":"publisher","first-page":"16268","DOI":"10.1073\/pnas.1002696107","volume":"107","author":"G Mari\u00f1o","year":"2010","unstructured":"Mari\u00f1o, G. et al. Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function. Proc. Natl Acad. Sci. USA 107, 16268\u201316273 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"970_CR88","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/alz.12240","volume":"17","author":"YW Kim","year":"2021","unstructured":"Kim, Y. W. et al. Harnessing the paradoxical phenotypes of APOE \u025b2 and APOE \u025b4 to identify genetic modifiers in Alzheimer\u2019s disease. Alzheimers Dement. 17, 831\u2013846 (2021).","journal-title":"Alzheimers Dement."},{"key":"970_CR89","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1056\/NEJMoa013100","volume":"350","author":"HM Domen\u00e9","year":"2004","unstructured":"Domen\u00e9, H. M. et al. Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. N. Engl. J. Med. 350, 570\u2013577 (2004).","journal-title":"N. Engl. J. Med."},{"key":"970_CR90","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1210\/jc.2005-2842","volume":"91","author":"V Hwa","year":"2006","unstructured":"Hwa, V. et al. Total absence of functional acid labile subunit, resulting in severe insulin-like growth factor deficiency and moderate growth failure. J. Clin. Endocrinol. Metab. 91, 1826\u20131831 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR91","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1210\/me.2010-0295","volume":"25","author":"SM Firth","year":"2011","unstructured":"Firth, S. M., Yan, X. & Baxter, R. C. D440N mutation in the acid-labile subunit of insulin-like growth factor complexes inhibits secretion and complex formation. Mol. Endocrinol. 25, 307\u2013314 (2011).","journal-title":"Mol. Endocrinol."},{"key":"970_CR92","first-page":"129","volume":"72","author":"HM Domen\u00e9","year":"2009","unstructured":"Domen\u00e9, H. M. et al. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences. Horm. Res. 72, 129\u2013141 (2009).","journal-title":"Horm. Res."},{"key":"970_CR93","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1210\/jc.2010-0489","volume":"95","author":"OV Fofanova-Gambetti","year":"2010","unstructured":"Fofanova-Gambetti, O. V. et al. Impact of heterozygosity for acid-labile subunit (IGFALS) gene mutations on stature: results from the international acid-labile subunit consortium. J. Clin. Endocrinol. Metab. 95, 4184\u20134191 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR94","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1530\/EJE-08-0081","volume":"159","author":"HA van Duyvenvoorde","year":"2008","unstructured":"van Duyvenvoorde, H. A. et al. Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit. Eur. J. Endocrinol. 159, 113\u2013120 (2008).","journal-title":"Eur. J. Endocrinol."},{"key":"970_CR95","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/cen.12200","volume":"79","author":"O Hess","year":"2013","unstructured":"Hess, O. et al. A novel mutation in IGFALS, c.380T>C (p.L127P), associated with short stature, delayed puberty, osteopenia and hyperinsulinaemia in two siblings: insights into the roles of insulin growth factor-1 (IGF1). Clin. Endocrinol. 79, 838\u2013844 (2013).","journal-title":"Clin. Endocrinol."},{"key":"970_CR96","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000355412","volume":"80","author":"HM Domen\u00e9","year":"2013","unstructured":"Domen\u00e9, H. M. et al. Heterozygous IGFALS gene variants in idiopathic short stature and normal children: impact on height and the IGF system. Horm. Res. Paediatr. 80, 413\u2013423 (2013).","journal-title":"Horm. Res. Paediatr."},{"key":"970_CR97","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1530\/EJE-16-0999","volume":"176","author":"E I\u015f\u0131k","year":"2017","unstructured":"I\u015f\u0131k, E. et al. Clinical and biochemical characteristics and bone mineral density of homozygous, compound heterozygous and heterozygous carriers of three novel IGFALS mutations. Eur. J. Endocrinol. 176, 657\u2013667 (2017).","journal-title":"Eur. J. Endocrinol."},{"key":"970_CR98","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1515\/jpem-2019-0234","volume":"33","author":"A Kumar","year":"2020","unstructured":"Kumar, A. et al. Pathogenic\/likely pathogenic variants in the SHOX, GHR and IGFALS genes among Indian children with idiopathic short stature. J. Pediatr. Endocrinol. Metab. 33, 79\u201388 (2020).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"970_CR99","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12020-022-03244-z","volume":"79","author":"A Franzoni","year":"2023","unstructured":"Franzoni, A. et al. Novel IGFALS mutations with predicted pathogenetic effects by the analysis of AlphaFold structure. Endocrine 79, 292\u2013295 (2023).","journal-title":"Endocrine"},{"key":"970_CR100","doi-asserted-by":"publisher","first-page":"111006","DOI":"10.1016\/j.mce.2020.111006","volume":"518","author":"S Domen\u00e9","year":"2020","unstructured":"Domen\u00e9, S. & Domen\u00e9, H. M. The role of acid-labile subunit (ALS) in the modulation of GH-IGF-I action. Mol. Cell Endocrinol. 518, 111006 (2020).","journal-title":"Mol. Cell Endocrinol."},{"key":"970_CR101","doi-asserted-by":"publisher","first-page":"E703","DOI":"10.1210\/jc.2013-3718","volume":"99","author":"W H\u00f6gler","year":"2014","unstructured":"H\u00f6gler, W. et al. IGFALS gene dosage effects on serum IGF-I and glucose metabolism, body composition, bone growth in length and width, and the pharmacokinetics of recombinant human IGF-I administration. J. Clin. Endocrinol. Metab. 99, E703\u2013E712 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR102","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000355017","volume":"81","author":"A Grandone","year":"2014","unstructured":"Grandone, A. et al. Clinical features of a new acid-labile subunit (IGFALS) heterozygous mutation: anthropometric and biochemical characterization and response to growth hormone administration. Horm. Res. Paediatr. 81, 67\u201372 (2014).","journal-title":"Horm. Res. Paediatr."},{"key":"970_CR103","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.2337\/diabetes.52.10.2483","volume":"52","author":"M Haluzik","year":"2003","unstructured":"Haluzik, M. et al. Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance. Diabetes 52, 2483\u20132489 (2003).","journal-title":"Diabetes"},{"key":"970_CR104","first-page":"1371","volume":"81","author":"H de Boer","year":"1996","unstructured":"de Boer, H. et al. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. J. Clin. Endocrinol. Metab. 81, 1371\u20131377 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR105","first-page":"223","volume":"82","author":"M Thor\u00e9n","year":"1997","unstructured":"Thor\u00e9n, M. et al. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency. J. Clin. Endocrinol. Metab. 82, 223\u2013228 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR106","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1210\/jcem.83.11.5223","volume":"83","author":"WM Drake","year":"1998","unstructured":"Drake, W. M. et al. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J. Clin. Endocrinol. Metab. 83, 3913\u20133919 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR107","first-page":"3001","volume":"86","author":"P Marzullo","year":"2001","unstructured":"Marzullo, P. et al. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. J. Clin. Endocrinol. Metab. 86, 3001\u20133008 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR108","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1507\/endocrj.49.379","volume":"49","author":"I Fukuda","year":"2002","unstructured":"Fukuda, I. et al. Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF)-I and IGF-binding protein-3. Endocr. J. 49, 379\u2013386 (2002).","journal-title":"Endocr. J."},{"key":"970_CR109","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1530\/eje.0.1440245","volume":"144","author":"V Barrios","year":"2001","unstructured":"Barrios, V. et al. Diagnostic interest of acid-labile subunit measurement in relationship to other components of the IGF system in pediatric patients with growth or eating disorders. Eur. J. Endocrinol. 144, 245\u2013250 (2001).","journal-title":"Eur. J. Endocrinol."},{"key":"970_CR110","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000512336","volume":"93","author":"DA Ertl","year":"2020","unstructured":"Ertl, D. A. et al. Diagnostic value of serum acid-labile subunit alone and in combination with IGF-I and IGFBP-3 in the diagnosis of growth hormone deficiency. Horm. Res. Paediatr. 93, 371\u2013379 (2020).","journal-title":"Horm. Res. Paediatr."},{"key":"970_CR111","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0504","volume":"12","author":"KCJ Yuen","year":"2023","unstructured":"Yuen, K. C. J. et al. Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis. Endocr. Connect. 12, e220504 (2023).","journal-title":"Endocr. Connect."},{"key":"970_CR112","first-page":"1091","volume":"86","author":"M Arosio","year":"2001","unstructured":"Arosio, M. et al. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3. J. Clin. Endocrinol. Metab. 86, 1091\u20131098 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR113","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/S1096-6374(01)80010-1","volume":"11","author":"KM Morrison","year":"2001","unstructured":"Morrison, K. M., Wu, Z., Bidlingmaier, M. & Strasburger, C. J. Findings and theoretical considerations on the usefulness of the acid-labile subunit in the monitoring of acromegaly. Growth Horm. IGF Res. 11, S61\u2013S63 (2001).","journal-title":"Growth Horm. IGF Res."},{"key":"970_CR114","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","volume":"21","author":"A Giustina","year":"2020","unstructured":"Giustina, A. et al. Multidisciplinary management of acromegaly: a consensus. Rev. Endocr. Metab. Disord. 21, 667\u2013678 (2020).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"970_CR115","first-page":"3591","volume":"84","author":"JD Wallace","year":"1999","unstructured":"Wallace, J. D. et al. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. J. Clin. Endocrinol. Metab. 84, 3591\u20133601 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR116","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1210\/clinem\/dgab799","volume":"107","author":"T Equey","year":"2022","unstructured":"Equey, T. et al. Application of the athlete biological passport approach to the detection of growth hormone doping. J. Clin. Endocrinol. Metab. 107, 649\u2013659 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR117","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/hep.25870","volume":"56","author":"O Neumann","year":"2012","unstructured":"Neumann, O. et al. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors. Hepatology 56, 1817\u20131827 (2012).","journal-title":"Hepatology"},{"key":"970_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-015-0077-1","volume":"7","author":"S Udali","year":"2015","unstructured":"Udali, S. et al. DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma. Clin. Epigenet. 7, 43 (2015).","journal-title":"Clin. Epigenet."},{"key":"970_CR119","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jhep.2013.10.014","volume":"60","author":"JU Marquardt","year":"2014","unstructured":"Marquardt, J. U. et al. Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits. J. Hepatol. 60, 346\u2013353 (2014).","journal-title":"J. Hepatol."},{"key":"970_CR120","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3390\/life12050701","volume":"12","author":"J Yu","year":"2022","unstructured":"Yu, J., Zhang, H., Zhang, Y. & Zhang, X. Integrated analysis of the altered lncRNA, microRNA, and mRNA expression in HBV-positive hepatocellular carcinoma. Life 12, 701 (2022).","journal-title":"Life"},{"key":"970_CR121","doi-asserted-by":"publisher","first-page":"2469592","DOI":"10.1155\/2022\/2469592","volume":"2022","author":"S Ge","year":"2022","unstructured":"Ge, S. et al. Identification of the diagnostic biomarker VIPR1 in hepatocellular carcinoma based on machine learning algorithm. J. Oncol. 2022, 2469592 (2022).","journal-title":"J. Oncol."},{"key":"970_CR122","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.3390\/cancers14225721","volume":"14","author":"J Ye","year":"2022","unstructured":"Ye, J. et al. Prognosis-related molecular subtypes and immune features associated with hepatocellular carcinoma. Cancers 14, 5721 (2022).","journal-title":"Cancers"},{"key":"970_CR123","doi-asserted-by":"publisher","first-page":"1051353","DOI":"10.3389\/fimmu.2022.1051353","volume":"13","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. Novel potential biomarkers for severe alcoholic liver disease. Front. Immunol. 13, 1051353 (2022).","journal-title":"Front. Immunol."},{"key":"970_CR124","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1158\/1055-9965.EPI-09-0836","volume":"19","author":"LA Mucci","year":"2010","unstructured":"Mucci, L. A. et al. Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective study. Cancer Epidemiol. Biomark. Prev. 19, 484\u2013491 (2010).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"970_CR125","doi-asserted-by":"publisher","first-page":"pkab091","DOI":"10.1093\/jncics\/pkab091","volume":"6","author":"C Ma","year":"2022","unstructured":"Ma, C. et al. Circulating insulin-like growth factor 1-related biomarkers and risk of lethal prostate cancer. JNCI Cancer Spectr. 6, pkab091 (2022).","journal-title":"JNCI Cancer Spectr."},{"key":"970_CR126","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/pros.20972","volume":"69","author":"M Johansson","year":"2009","unstructured":"Johansson, M. et al. Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival. Prostate 69, 1281\u20131291 (2009).","journal-title":"Prostate"},{"key":"970_CR127","doi-asserted-by":"publisher","first-page":"dju085","DOI":"10.1093\/jnci\/dju218","volume":"106","author":"Y Cao","year":"2014","unstructured":"Cao, Y. et al. Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival. J. Natl Cancer Inst. 106, dju085 (2014).","journal-title":"J. Natl Cancer Inst."},{"key":"970_CR128","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1158\/1078-0432.CCR-18-2423","volume":"25","author":"J Chen","year":"2019","unstructured":"Chen, J. et al. High-resolution bisulfite-sequencing of peripheral blood DNA methylation in early-onset and familial risk breast cancer patients. Clin. Cancer Res. 25, 5301\u20135314 (2019).","journal-title":"Clin. Cancer Res."},{"key":"970_CR129","doi-asserted-by":"publisher","first-page":"453","DOI":"10.21037\/atm.2020.04.02","volume":"8","author":"F Wang","year":"2020","unstructured":"Wang, F., Tang, C., Gao, X. & Xu, J. Identification of a six-gene signature associated with tumor mutation burden for predicting prognosis in patients with invasive breast carcinoma. Ann. Transl. Med. 8, 453 (2020).","journal-title":"Ann. Transl. Med."},{"key":"970_CR130","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.18632\/aging.204209","volume":"14","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y., Zhang, Y., Dai, C., Hong, K. & Guo, Y. A signature constructed with mitophagy-related genes to predict the prognosis and therapy response for breast cancer. Aging 14, 6169\u20136186 (2022).","journal-title":"Aging"},{"key":"970_CR131","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/sj.bjc.6602936","volume":"94","author":"F Canzian","year":"2006","unstructured":"Canzian, F. et al. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br. J. Cancer 94, 299\u2013307 (2006).","journal-title":"Br. J. Cancer"},{"key":"970_CR132","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10549-006-9420-8","volume":"104","author":"SL Deming","year":"2007","unstructured":"Deming, S. L. et al. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study. Breast Cancer Res. Treat. 104, 309\u2013319 (2007).","journal-title":"Breast Cancer Res. Treat."},{"key":"970_CR133","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s10549-010-0778-2","volume":"123","author":"CW Taverne","year":"2010","unstructured":"Taverne, C. W. et al. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density. Breast Cancer Res. Treat. 123, 843\u2013855 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"970_CR134","first-page":"110","volume":"75","author":"WH Daughaday","year":"1992","unstructured":"Daughaday, W. H. & Trivedi, B. Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. J. Clin. Endocrinol. Metab. 75, 110\u2013115 (1992).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR135","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1172\/JCI116152","volume":"90","author":"J Zapf","year":"1992","unstructured":"Zapf, J., Futo, E., Peter, M. & Froesch, E. R. Can \u2018big\u2019 insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J. Clin. Invest. 90, 2574\u20132584 (1992).","journal-title":"J. Clin. Invest."},{"key":"970_CR136","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1210\/er.2012-1033","volume":"34","author":"Y Dynkevich","year":"2013","unstructured":"Dynkevich, Y. et al. Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive. Endocr. Rev. 34, 798\u2013826 (2013).","journal-title":"Endocr. Rev."},{"key":"970_CR137","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1210\/jcem-73-4-696","volume":"73","author":"RC Baxter","year":"1991","unstructured":"Baxter, R. C. & Daughaday, W. H. Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors. J. Clin. Endocrinol. Metab. 73, 696\u2013702 (1991).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR138","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/BF02935648","volume":"3","author":"WH Daughaday","year":"1995","unstructured":"Daughaday, W. H., Trivedi, B. & Baxter, R. C. Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid labile subunit and leads to elevation of serum free IGF-II. Endocrine 3, 425\u2013428 (1995).","journal-title":"Endocrine"},{"key":"970_CR139","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/000456329202900312","volume":"29","author":"JD Teale","year":"1992","unstructured":"Teale, J. D., Blum, W. F. & Marks, V. Alleviation of non-islet cell tumour hypoglycaemia by growth hormone therapy is associated with changes in IGF binding protein-3. Ann. Clin. Biochem. 29, 314\u2013323 (1992).","journal-title":"Ann. Clin. Biochem."},{"key":"970_CR140","first-page":"2700","volume":"80","author":"RC Baxter","year":"1995","unstructured":"Baxter, R. C. et al. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. J. Clin. Endocrinol. Metab. 80, 2700\u20132708 (1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR141","first-page":"1141","volume":"81","author":"LE Katz","year":"1996","unstructured":"Katz, L. E. et al. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia. J. Clin. Endocrinol. Metab. 81, 1141\u20131146 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR142","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1677\/joe.0.1650253","volume":"165","author":"JJ Bond","year":"2000","unstructured":"Bond, J. J., Meka, S. & Baxter, R. C. Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6. J. Endocrinol. 165, 253\u2013260 (2000).","journal-title":"J. Endocrinol."},{"key":"970_CR143","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1074\/jbc.275.6.3841","volume":"275","author":"YR Boisclair","year":"2000","unstructured":"Boisclair, Y. R., Wang, J., Shi, J., Hurst, K. R. & Ooi, G. T. Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1beta on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells. J. Biol. Chem. 275, 3841\u20133847 (2000).","journal-title":"J. Biol. Chem."},{"key":"970_CR144","doi-asserted-by":"publisher","first-page":"E692","DOI":"10.1152\/ajpendo.00148.2002","volume":"283","author":"SE Kong","year":"2002","unstructured":"Kong, S. E., Firth, S. M., Baxter, R. C. & Delhanty, P. J. Regulation of the acid-labile subunit in sustained endotoxemia. Am. J. Physiol. Endocrinol. Metab. 283, E692\u2013E701 (2002).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"970_CR145","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1096-6374(98)80298-0","volume":"8","author":"RC Baxter","year":"1998","unstructured":"Baxter, R. C., Hawker, F. H., To, C., Stewart, P. M. & Holman, S. R. Thirty-day monitoring of insulin-like growth factors and their binding proteins in intensive care unit patients. Growth Horm. IGF Res. 8, 455\u2013463 (1998).","journal-title":"Growth Horm. IGF Res."},{"key":"970_CR146","first-page":"183","volume":"85","author":"G Van den Berghe","year":"2000","unstructured":"Van den Berghe, G. et al. A paradoxical gender dissociation within the growth hormone\/insulin-like growth factor I axis during protracted critical illness. J. Clin. Endocrinol. Metab. 85, 183\u2013192 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"970_CR147","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tox.2012.12.017","volume":"304","author":"BM Flannery","year":"2013","unstructured":"Flannery, B. M., Amuzie, C. J. & Pestka, J. J. Evaluation of insulin-like growth factor acid-labile subunit as a potential biomarker of effect for deoxynivalenol-induced proinflammatory cytokine expression. Toxicology 304, 192\u2013198 (2013).","journal-title":"Toxicology"},{"key":"970_CR148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278708","volume":"17","author":"A Ruiz-Sanmart\u00edn","year":"2022","unstructured":"Ruiz-Sanmart\u00edn, A. et al. Characterization of a proteomic profile associated with organ dysfunction and mortality of sepsis and septic shock. PLoS ONE\u00a017, e0278708 (2022).","journal-title":"PLoS ONE"},{"key":"970_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-022-09345-1","volume":"19","author":"MT Salie","year":"2022","unstructured":"Salie, M. T. et al. Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases. Clin. Proteom. 19, 7 (2022).","journal-title":"Clin. Proteom."},{"key":"970_CR150","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/s41423-021-00649-0","volume":"18","author":"G Xu","year":"2021","unstructured":"Xu, G. et al. Virus-inducible IGFALS facilitates innate immune responses by mediating IRAK1 and TRAF6 activation. Cell Mol. Immunol. 18, 1587\u20131589 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"970_CR151","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202000278","volume":"21","author":"JS Lee","year":"2021","unstructured":"Lee, J. S. et al. Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression. Proteomics 21, e2000278 (2021).","journal-title":"Proteomics"},{"key":"970_CR152","doi-asserted-by":"publisher","first-page":"100277","DOI":"10.1016\/j.mcpro.2022.100277","volume":"21","author":"VR Richard","year":"2022","unstructured":"Richard, V. R. et al. Early prediction of COVID-19 patient survival by targeted plasma multi-omics and machine learning. Mol. Cell Proteom. 21, 100277 (2022).","journal-title":"Mol. Cell Proteom."},{"key":"970_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98253-9","volume":"11","author":"Y Kimura","year":"2021","unstructured":"Kimura, Y. et al. Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach. Sci. Rep. 11, 20638 (2021).","journal-title":"Sci. Rep."},{"key":"970_CR154","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101099","volume":"4","author":"F V\u00f6llmy","year":"2021","unstructured":"V\u00f6llmy, F. et al. A serum proteome signature to predict mortality in severe COVID-19 patients. Life Sci. Alliance 4, e202101099 (2021).","journal-title":"Life Sci. Alliance"},{"key":"970_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04683-w","volume":"12","author":"J Calvet","year":"2022","unstructured":"Calvet, J. et al. Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission. Sci. Rep. 12, 640 (2022).","journal-title":"Sci. Rep."},{"key":"970_CR156","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1365-2265.2004.02136.x","volume":"61","author":"F Fischer","year":"2004","unstructured":"Fischer, F. et al. Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease. Clin. Endocrinol. 61, 595\u2013602 (2004).","journal-title":"Clin. Endocrinol."},{"key":"970_CR157","doi-asserted-by":"publisher","DOI":"10.1186\/gm169","volume":"2","author":"RL Prentice","year":"2010","unstructured":"Prentice, R. L. et al. Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling. Genome Med. 2, 48 (2010).","journal-title":"Genome Med."},{"key":"970_CR158","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/biom12101419","volume":"12","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. Systemic biomarkers and unique pathways in different phenotypes of heart failure with preserved ejection fraction. Biomolecules 12, 1419 (2022).","journal-title":"Biomolecules"},{"key":"970_CR159","doi-asserted-by":"publisher","first-page":"106171","DOI":"10.1016\/j.isci.2023.106171","volume":"26","author":"W Heyse","year":"2023","unstructured":"Heyse, W. et al. Identification of patient subtypes based on protein expression for prediction of heart failure after myocardial infarction. iScience 26, 106171 (2023).","journal-title":"iScience"},{"key":"970_CR160","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/ejh.12879","volume":"98","author":"WE Wysokinski","year":"2017","unstructured":"Wysokinski, W. E. et al. Impact of atrial fibrillation on platelet gene expression. Eur. J. Haematol. 98, 615\u2013621 (2017).","journal-title":"Eur. J. Haematol."},{"key":"970_CR161","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1046\/j.1365-2265.1996.726547.x","volume":"44","author":"A Bereket","year":"1996","unstructured":"Bereket, A. et al. Regulation of the acid-labile subunit of the insulin-like growth factor ternary complex in patients with insulin-dependent diabetes mellitus and severe burns. Clin. Endocrinol. 44, 525\u2013532 (1996).","journal-title":"Clin. Endocrinol."},{"key":"970_CR162","doi-asserted-by":"publisher","first-page":"917823","DOI":"10.1155\/2014\/917823","volume":"2014","author":"YC Lai","year":"2014","unstructured":"Lai, Y. C., Li, H. Y., Wu, T. J., Jeng, C. Y. & Chuang, L. M. Correlation of circulating acid-labile subunit levels with insulin sensitivity and serum LDL cholesterol in patients with type 2 diabetes: findings from a prospective study with rosiglitazone. PPAR Res. 2014, 917823 (2014).","journal-title":"PPAR Res."},{"key":"970_CR163","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nsmb.2519","volume":"20","author":"NJ Kershaw","year":"2013","unstructured":"Kershaw, N. J. et al. SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition. Nat. Struct. Mol. Biol. 20, 469\u2013476 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"970_CR164","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.cellsig.2009.07.009","volume":"21","author":"HD Woolson","year":"2009","unstructured":"Woolson, H. D., Thomson, V. S., Rutherford, C., Yarwood, S. J. & Palmer, T. M. Selective inhibition of cytokine-activated extracellular signal-regulated kinase by cyclic AMP via Epac1-dependent induction of suppressor of cytokine signalling-3. Cell Signal. 21, 1706\u20131715 (2009).","journal-title":"Cell Signal."},{"key":"970_CR165","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1074\/jbc.M707492200","volume":"283","author":"E Cocolakis","year":"2008","unstructured":"Cocolakis, E. et al. Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation. J. Biol. Chem. 283, 1293\u20131307 (2008).","journal-title":"J. Biol. Chem."},{"key":"970_CR166","doi-asserted-by":"publisher","first-page":"9573","DOI":"10.1073\/pnas.160099797","volume":"97","author":"M Bianchi","year":"2000","unstructured":"Bianchi, M., Meng, C. & Ivashkiv, L. B. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids. Proc. Natl Acad. Sci. USA 97, 9573\u20139578 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"970_CR167","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-021-02777-w","volume":"11","author":"S Wei","year":"2021","unstructured":"Wei, S. & Qiu, Y. MiR-210-5p regulates STAT3 activation by targeting STAT5A in the differentiation of dermal fibroblasts. 3 Biotech 11, 243 (2021).","journal-title":"3 Biotech"},{"key":"970_CR168","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1021\/acs.jproteome.0c00365","volume":"19","author":"A D\u2019Alessandro","year":"2020","unstructured":"D\u2019Alessandro, A. et al. Serum proteomics in COVID-19 patients: altered coagulation and complement status as a function of IL-6 level. J. Proteome Res. 19, 4417\u20134427 (2020).","journal-title":"J. Proteome Res."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-00970-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-00970-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-00970-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T13:03:14Z","timestamp":1718370194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-024-00970-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":168,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["970"],"URL":"https:\/\/doi.org\/10.1038\/s41574-024-00970-4","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"26 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}